Stocks and Investing Stocks and Investing
Tue, October 4, 2022
Mon, October 3, 2022

Maury Raycroft Maintained (ALNY) at Strong Buy with Increased Target to $232 on, Oct 3rd, 2022


Published on 2024-10-27 23:10:45 - WOPRAI, Maury Raycroft
  Print publication without navigation


Maury Raycroft of Jefferies, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $218 to $232 on, Oct 3rd, 2022.

Maury has made no other calls on ALNY in the last 4 months.



There are 11 other peers that have a rating on ALNY. Out of the 11 peers that are also analyzing ALNY, 6 agree with Maury's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $222 on, Friday, September 9th, 2022
  • Gary Nachman of "BMO Capital" Maintained at Hold with Increased Target to $200 on, Friday, September 9th, 2022
  • David Lebowitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $164 on, Friday, July 15th, 2022
  • Olivia Brayer of "Cantor Fitzgerald" Initiated at Hold and Held Target at $175 on, Wednesday, July 13th, 2022
  • Debjit Chattopadhyay of "Guggenheim" Downgraded from Strong Buy to Hold on, Monday, June 27th, 2022
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $98 on, Wednesday, June 15th, 2022


These are the ratings of the 5 analyists that currently disagree with Maury


  • Luca Issi of "RBC Capital" Maintained at Buy with Increased Target to $250 on, Tuesday, September 20th, 2022
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $256 on, Friday, September 9th, 2022
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $240 on, Thursday, August 4th, 2022
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $250 on, Thursday, August 4th, 2022
  • Myles Minter of "William Blair" Initiated at Buy on, Tuesday, June 7th, 2022
Contributing Sources